Quarterly report pursuant to Section 13 or 15(d)

Capitalization (Details)

v3.24.2.u1
Capitalization (Details) - USD ($)
 6 Months Ended
May 24, 2024
Mar. 22, 2024
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Subsidiary, Sale of Stock          
Proceeds from private placement offering, net of offering costs paid     $ 42,234,000 $ 87,329,000  
Maximum amount of shares allowed to be owned by related party (as a percent) 49.99%        
Ownership Interest Contigency, Trigger Percentage 40.00%        
Securities Purchase Agreement          
Subsidiary, Sale of Stock          
Shares issued (in shares) 67,400,000        
Sales of stock (in dollars per share) $ 0.6270        
Class A Common Stock          
Subsidiary, Sale of Stock          
Common stock, shares authorized (in shares)     800,000,000   800,000,000
Common stock, par value (in dollars per share)     $ 0.0001   $ 0.0001
Class A Common Stock | Securities Purchase Agreement          
Subsidiary, Sale of Stock          
Shares issued (in shares) 41,600,000        
Shares issued per transaction (in shares) 1        
Number of shares issuable per warrant (warrants) 1        
Exercise price (in dollars per share) $ 0.5020        
Class A Common Stock | Securities Purchase Agreement | Common Warrants          
Subsidiary, Sale of Stock          
Warrant issued for securities (in shares) 67,400,000        
Class A Common Stock | Securities Purchase Agreement | Pre-funded warrants          
Subsidiary, Sale of Stock          
Warrant issued for securities (in shares) 25,800,000        
Class A Common Stock | Private Placement | Pre-funded warrants          
Subsidiary, Sale of Stock          
Sale of Stock, Consideration Received on Transaction $ 39,800,000        
Offering cost $ 2,400,000        
Class V Common Stock          
Subsidiary, Sale of Stock          
Common stock, shares authorized (in shares)     205,000,000   205,000,000
Common stock, par value (in dollars per share)     $ 0.0001   $ 0.0001
Line of Credit | VGS 2 Promissory Note          
Subsidiary, Sale of Stock          
Funding provided   $ 25,000,000      
Percentage of upfront-fee   1.50%      
Line of Credit | Period Two | VGS 2 Promissory Note          
Subsidiary, Sale of Stock          
Debt Instrument, Back End Fee   4.50%      
Line of Credit | Period Four | VGS 2 Promissory Note          
Subsidiary, Sale of Stock          
Debt Instrument, Back End Fee   9.00%      
Line of Credit | Period Three | VGS 2 Promissory Note          
Subsidiary, Sale of Stock          
Debt Instrument, Back End Fee   6.75%      
Line of Credit | Option One | VGS 2 Promissory Note          
Subsidiary, Sale of Stock          
Interest rate   17.50%      
Paid in cash interest, percentage   8.00%      
Paid in kind interest, percentage   9.50%      
Line of Credit | Option Two | VGS 2 Promissory Note          
Subsidiary, Sale of Stock          
Paid in kind interest, percentage   17.50%